NEW YORK (GenomeWeb) – The National Institutes of Health has awarded Rutgers New Jersey Medical School researcher David Alland a $640,000 grant to develop a rapid detection test for the Ebola virus.

The amplicon-nested PCR-based assay is designed to be performed on Cepheid's GeneXpert platform using the firm's assay cartridges.

The Ebola test would analyze small amounts of patients' blood or samples taken from cheek swabs. Alland said in a statement that he hopes to develop the assay within the next 15 months.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.